Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1

被引:281
作者
Moore, PL
Crooks, ET
Porter, L
Zhu, P
Cayanan, CS
Grise, H
Corcoran, P
Zwick, MB
Franti, M
Morris, L
Roux, KH
Burton, DR
Binley, JM
机构
[1] Torrey Pines Inst Mol Studies, San Diego, CA 92121 USA
[2] Natl Inst Communicable Dis, Johannesburg, South Africa
[3] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA
[4] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA
[5] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[6] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA
[7] Progen Pharmaceut Inc, Tarrytown, NY 10591 USA
关键词
D O I
10.1128/JVI.80.5.2515-2528.2006
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human immunodeficiency virus type I (HIV-1) neutralizing antibodies are thought be distinguished from nonneutralizing antibodies by their ability to recognize functional gp120/gp41 envelope glycoprotein (Env) trimers. The antibody responses induced by natural HIV-1 infection or by vaccine candidates tested to date consist largely of nonneutralizing antibodies. One might have expected a more vigorous neutralizing response, particularly against virus particles that bear functional trimers. The recent surprising observation that nonneutralizing antibodies can specifically capture HIV-1 may provide a clue relating to this paradox. Specifically, it was suggested that forms of Env, to which nonneutralizing antibodies can bind, exist on virus surfaces. Here, we present evidence that HIV-1 particles bear nonfunctional gp120/gp41 monomers and gp120-depleted gp41 stumps. Using a native electrophoresis band shift assay, we show that antibody-trimer binding predicts neutralization and that the nonfunctional forms of Env may account for virus capture by nonneutralizing antibodies. We hypothesize that these nonfunctional forms of Env on particle surfaces serve to divert the antibody response, helping the virus to evade neutralization.
引用
收藏
页码:2515 / 2528
页数:14
相关论文
共 74 条
  • [1] EPITOPE MAPPING AND TOPOLOGY OF BACULOVIRUS-EXPRESSED HIV-1 GP160 DETERMINED WITH A PANEL OF MURINE MONOCLONAL-ANTIBODIES
    ABACIOGLU, YH
    FOUTS, TR
    LAMAN, JD
    CLAASSEN, E
    PINCUS, SH
    MOORE, JP
    ROBY, CA
    KAMINLEWIS, R
    LEWIS, GK
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (04) : 371 - 381
  • [2] The cytoplasmic tail slows the folding of human immunodeficiency virus type 1 Env from a late prebundle configuration into the six-helix bundle
    Abrahamyan, LG
    Mkrtchyan, SR
    Binley, J
    Lu, M
    Melikyan, GB
    Cohen, FS
    [J]. JOURNAL OF VIROLOGY, 2005, 79 (01) : 106 - 115
  • [3] Human immunodeficiency virus type 1 Env with an intersubunit disulfide bond engages coreceptors but requires bond reduction after engagement to induce fusion
    Abrahamyan, LG
    Markosyan, RM
    Moore, JP
    Cohen, FS
    Melikyan, GB
    [J]. JOURNAL OF VIROLOGY, 2003, 77 (10) : 5829 - 5836
  • [4] EXPRESSION AND CHARACTERIZATION OF CD4-IGG(2), A NOVEL HETEROTETRAMER THAT NEUTRALIZES PRIMARY HIV TYPE-1 ISOLATES
    ALLAWAY, GP
    DAVISBRUNO, KL
    BEAUDRY, GA
    GARCIA, EB
    WONG, EL
    RYDER, AM
    HASEL, KW
    GAUDUIN, MC
    KOUP, RA
    MCDOUGAL, JS
    MADDON, PJ
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (05) : 533 - 539
  • [5] Design of a novel peptide inhibitor of HIV fusion that disrupts the internal trimeric coiled-coil of gp41
    Bewley, CA
    Louis, JM
    Ghirlando, R
    Clore, GM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (16) : 14238 - 14245
  • [6] Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies
    Binley, JA
    Wrin, T
    Korber, B
    Zwick, MB
    Wang, M
    Chappey, C
    Stiegler, G
    Kunert, R
    Zolla-Pazner, S
    Katinger, H
    Petropoulos, CJ
    Burton, DR
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (23) : 13232 - 13252
  • [7] Human antibody responses to HIV type 1 glycoprotein 41 cloned in phage display libraries suggest three major epitopes are recognized and give evidence for conserved antibody motifs in antigen binding
    Binley, JM
    Ditzel, HJ
    Barbas, CF
    Sullivan, N
    Sodroski, J
    Parren, PWHI
    Burton, DR
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (10) : 911 - 924
  • [8] Analysis of the interaction of antibodies with a conserved, enzymatically deglycosylated core of the HIV type 1 envelope glycoprotein 120
    Binley, JM
    Wyatt, R
    Desjardins, E
    Kwong, PD
    Hendrickson, W
    Moore, JP
    Sodroski, J
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (03) : 191 - 198
  • [9] Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions
    Binley, JM
    Cayanan, CS
    Wiley, C
    Schülke, N
    Olson, WC
    Burton, DR
    [J]. JOURNAL OF VIROLOGY, 2003, 77 (10) : 5678 - 5684
  • [10] Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1
    Binley, JM
    Klasse, PJ
    Cao, YZ
    Jones, I
    Markowitz, M
    Ho, DD
    Moore, JP
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (04) : 2799 - 2809